Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
China
· Delayed Price · Currency is CNY 10.74
+0.11 (1.03%)
At close: May 16, 2025, 2:57 PM CST
SHE:301126 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 35.04 | 51.33 | 34.3 | 51.08 | 68.26 | 64.85 | Upgrade
|
| Depreciation & Amortization | 146.82 | 146.82 | 82.66 | 42.28 | 22.68 | 12.59 | Upgrade
|
| Other Amortization | 22.52 | 22.52 | 16.91 | 9.1 | 3.33 | 1.51 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.38 | -1.38 | -1.11 | -0.32 | - | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 22.39 | 22.39 | 0.48 | 0.01 | 13.52 | 4.16 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.03 | -0.03 | -1.24 | -0.32 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 14.92 | 16.74 | - | - | Upgrade
|
| Other Operating Activities | 98.21 | 107.82 | 87.39 | 47.37 | 34.96 | 31.55 | Upgrade
|
| Change in Accounts Receivable | -337.18 | -337.18 | -164.94 | -374.6 | -438.62 | -45.21 | Upgrade
|
| Change in Inventory | -51.3 | -51.3 | -116.38 | -125.59 | 36.29 | -102.91 | Upgrade
|
| Change in Accounts Payable | 136.15 | 136.15 | 99.6 | -156.91 | 115.04 | -118.94 | Upgrade
|
| Change in Other Net Operating Assets | -63.39 | -63.39 | -13.87 | 0.86 | -15.14 | - | Upgrade
|
| Operating Cash Flow | -1.86 | 24.04 | 27.13 | -493.96 | -161.81 | -151.46 | Upgrade
|
| Operating Cash Flow Growth | - | -11.39% | - | - | - | - | Upgrade
|
| Capital Expenditures | -149.2 | -187.14 | -226.7 | -208.73 | -33.29 | -45.95 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.26 | 1.28 | 0.22 | 0.08 | - | - | Upgrade
|
| Cash Acquisitions | -496.86 | -496.86 | -412.22 | -127.74 | - | - | Upgrade
|
| Investment in Securities | 333.47 | - | 7.1 | -120 | - | - | Upgrade
|
| Other Investing Activities | -5.27 | -5.27 | -167.25 | -47.96 | - | - | Upgrade
|
| Investing Cash Flow | -316.6 | -687.98 | -798.84 | -504.34 | -33.29 | -45.95 | Upgrade
|
| Long-Term Debt Issued | - | 2,321 | 2,351 | 1,608 | 819.64 | 791.73 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -17.91 | Upgrade
|
| Long-Term Debt Repaid | - | -1,741 | -1,382 | -780.55 | -788.91 | -553.85 | Upgrade
|
| Total Debt Repaid | -1,936 | -1,741 | -1,382 | -780.55 | -788.91 | -571.76 | Upgrade
|
| Net Debt Issued (Repaid) | 431.72 | 580.07 | 968.66 | 827.08 | 30.73 | 219.97 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.49 | 596.17 | - | Upgrade
|
| Common Dividends Paid | -95.41 | -92.35 | -72.45 | -41.22 | -30.97 | -30.97 | Upgrade
|
| Dividends Paid | -95.41 | -92.35 | -72.45 | -41.22 | -30.97 | -30.97 | Upgrade
|
| Other Financing Activities | 53.6 | 83.28 | -31.74 | - | 102.9 | 75.31 | Upgrade
|
| Financing Cash Flow | 389.01 | 571 | 864.47 | 786.34 | 698.83 | 264.32 | Upgrade
|
| Net Cash Flow | 70.55 | -92.94 | 92.76 | -211.96 | 503.73 | 66.9 | Upgrade
|
| Free Cash Flow | -151.06 | -163.1 | -199.57 | -702.69 | -195.1 | -197.41 | Upgrade
|
| Free Cash Flow Margin | -2.88% | -3.12% | -5.11% | -21.34% | -7.53% | -8.44% | Upgrade
|
| Free Cash Flow Per Share | -0.80 | -0.80 | -0.99 | -3.44 | -1.26 | -1.28 | Upgrade
|
| Cash Income Tax Paid | 139.15 | 129.84 | 99.43 | 88.67 | 80.45 | 129.62 | Upgrade
|
| Levered Free Cash Flow | 134.39 | -195.95 | 27.05 | -643.98 | -59.8 | -186.25 | Upgrade
|
| Unlevered Free Cash Flow | 134.39 | -195.95 | 70.5 | -618.51 | -38 | -166.53 | Upgrade
|
| Change in Net Working Capital | 6.3 | 309.02 | -120.98 | 528.81 | 110.9 | 210.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.